Adderall

Adderall is a prescription stimulant made of mixed amphetamine salts (a 3:1 ratio of dextroamphetamine and levoamphetamine). It's prescribed for ADHD and narcolepsy, and it works by pushing your brain to release more dopamine and noradrenaline, the two neurotransmitters that drive focus, motivation, and arousal. The result, for people with ADHD, is calmer, more directed thinking. For people without ADHD, the result is mostly a feeling of being switched on, plus a strong jolt to heart rate and adrenaline that often gets mistaken for cognitive enhancement.

The honest truth is that it works extremely well for ADHD, has a real but modest effect on cognition in healthy adults, and carries meaningful long-term costs (tolerance, sleep disruption, cardiovascular load, dependence) that scale with dose and duration.

Deep-dive

Adderall acts on the catecholamine system through several mechanisms at once. It enters dopamine and noradrenaline neurons via their reuptake transporters (DAT and NET), then reverses those transporters so they pump neurotransmitter out into the synapse instead of clearing it. It also enters synaptic vesicles via VMAT2 and displaces the neurotransmitter stored inside, flooding the cytoplasm. And it inhibits monoamine oxidase modestly, slowing the enzyme that breaks dopamine down. The combined effect is a large, sustained rise in extracellular dopamine and noradrenaline in the prefrontal cortex and striatum, the brain regions that handle attention, working memory, and executive control.

The FDA prescribing information itself notes that the therapeutic mechanism in ADHD is not fully understood, only that the drug elevates catecholamines. The dominant model is that ADHD brains have weaker tonic dopamine and noradrenaline signalling in the prefrontal cortex, and Adderall restores it to a more typical range, which is why people with ADHD often describe feeling calmer rather than amped on it. In a brain that already has adequate signalling, the same dose pushes the system above optimal and produces the more familiar stimulant experience: hyperfocus, euphoria, elevated heart rate, suppressed appetite.

ADHD efficacy. This is the strongest evidence base. Stimulants are the most effective class of medication for ADHD across all of psychiatry, with effect sizes that are large for core symptoms and consistent across decades of trials. Both immediate-release and extended-release forms work; the practical difference is duration and dosing convenience.

Cognitive enhancement in healthy people. Much weaker than the cultural narrative suggests. A 2020 meta-analysis covering 47 studies found d-amphetamine produced no significant overall effect on executive function, attention, or working memory in healthy non-sleep-deprived adults, with only a small benefit on memory consolidation. A direct placebo-controlled trial of 30 mg Adderall in healthy college students found minimal cognitive effects but large effects on autonomic activation, mood, and the subjective feeling of being smarter, a dissociation between feeling enhanced and actually performing better. The picture is consistent: Adderall reliably makes you feel sharper, but objective improvement in healthy users is small, inconsistent, and often offset by impaired flexibility and creativity.

Cardiovascular load. Modest in the short term, more concerning over time. Across meta-analyses of randomised trials, amphetamines raise systolic blood pressure by about 2 mmHg and resting heart rate by roughly 5 bpm in adults, with similar effects in children. A two-year extension study in children found systolic and diastolic increases of around 3 mmHg and a 3 bpm rise in pulse, called clinically insignificant by the authors but not zero. Large observational studies in adults haven't found a clear increase in serious cardiac events, but confidence intervals don't rule out modest elevations in sudden death and arrhythmia risk, particularly in people with underlying heart conditions. The proposed mechanisms include direct chronotropic effects, vasospasm from circulating catecholamines, and QT interval changes.

Tolerance and dopamine adaptation. Repeated stimulant exposure changes the dopamine system. A systematic review and meta-analysis of stimulant users found reduced D2/D3 receptor availability, reduced dopamine release in response to stimulants, and reduced dopamine transporter levels in chronic users. Some of this likely predates use and predisposes to it, but longitudinal evidence shows further reductions develop with chronic exposure. In practice this looks like rising doses to chase the original effect, blunted motivation off the drug, and an increasingly narrow window between therapeutic and uncomfortable. This is more pronounced with recreational misuse than with steady prescribed dosing, but it's not absent at therapeutic doses.

Sleep, appetite, mood. The three side effects that drive most discontinuation. Amphetamines suppress appetite via hypothalamic dopamine and noradrenaline, which is why weight loss is consistent and meaningful at standard doses. They delay sleep onset, suppress REM, and shorten total sleep time, with effects that can persist into the next night even when the dose is taken in the morning. The crash as the drug wears off can produce irritability, low mood, and brain fog, sometimes severe.

Women. This is where the standard prescribing information starts to fail. Pharmacokinetic data shows women metabolise amphetamine differently from men: at unadjusted doses, plasma amphetamine concentrations run 20-30% higher in women than in men primarily because of body mass and composition differences, not because of any female-specific metabolic pathway. CYP2D6 activity, which clears dextroamphetamine, also varies by sex and genotype, so women who are slow metabolisers can run substantially higher plasma levels at a standard dose.

The more interesting effect is the cycle. Oestrogen upregulates dopamine synthesis, release, and receptor sensitivity, which means women have meaningfully more sensitivity to stimulants in the high-oestrogen follicular phase and noticeably less in the luteal phase. A study by Justice and colleagues using 15 mg dextroamphetamine in 16 healthy women found subjective effects (feeling "high," "energetic," "intellectually efficient") were significantly stronger during the follicular phase. A pilot study in women treated with amphetamine salts for ADHD found ADHD symptoms were most severe during menstruation and mildest in the mid-follicular phase, tracking with oestrogen. A 2023 paper from a Dutch ADHD clinic showed that women who increased their stimulant dose in the premenstrual week saw improvement in both ADHD and mood symptoms, suggesting cycle-phase dose adjustment is a real, underused lever. None of this is in the FDA label, and most prescribers don't ask about it. If you menstruate and you find your medication "stops working" the week before your period, this is probably why, and a small dose adjustment in that window is worth discussing with your doctor.

Pregnancy is a hard stop. Amphetamines cross the placenta, and observational data link in-utero exposure to lower birth weight and possible developmental effects. Skip it unless your doctor has weighed the risk of untreated severe ADHD against the exposure and decided in favour of continuing.

Dosage:

Adderall IR (immediate-release): Adults typically start at 5 mg once or twice daily, increased by 5 mg weekly until effective. Onset is 15-30 minutes, duration 4-6 hours. Most adults stabilise between 10-30 mg/day total, divided into 2-3 doses. The maximum recommended daily dose is 40 mg

Adderall XR (extended-release): Adults typically start at 20 mg once daily in the morning, with subsequent adjustment based on response. Onset 30-60 minutes, duration 10-12 hours. Most studies show doses above 20 mg/day produce little additional benefit in adults

Take it in the morning. Doses after early afternoon will damage your sleep that night and the next, even if you can't feel the drug anymore

Take with or without food, but be consistent. Acidic foods and drinks (citrus, vitamin C in large doses) reduce absorption; alkalinising agents increase it. Pick a routine and stick with it

Eat anyway. Appetite suppression is the rule, not the exception. Set fixed mealtimes and eat on schedule even when you're not hungry. Skipping meals on Adderall is the fastest route to malnutrition, fatigue, and the worst version of the comedown

Hydrate aggressively. Stimulants suppress thirst signalling and increase fluid loss

Cycle awareness for women. If you menstruate and notice your dose feels weak the week before your period, that's a known oestrogen-dopamine effect. Some clinicians adjust dose upward by a small amount in the late luteal phase. Discuss with your prescriber rather than self-adjusting

Drug holidays. Some people take weekends off to reduce tolerance and let sleep, appetite, and mood reset. Useful for some, destabilising for others. Not recommended without prescriber input

Tolerance is real. If you find yourself needing more for the same effect, the answer is rarely a higher dose. It's usually a tolerance break, a switch to a different stimulant, or a hard look at sleep, food, and stress

Here's what you can expect:

If you have ADHD, the experience is often described as the noise quieting down. Tasks that felt impossible become approachable, you can hold a thought long enough to finish it, and the impulsivity loop loosens. The first dose is sometimes dramatic; the steady-state experience is usually less obvious but functionally transformative. People with ADHD don't typically describe feeling stimulated, they describe feeling normal.

If you don't have ADHD, the experience is more like classic stimulant arousal: heart rate up, focus narrowed onto whatever you point it at, talkativeness, mild euphoria, suppressed appetite, suppressed need for sleep. You'll feel sharp. Whether you actually perform better at complex cognitive work is a different question, and the evidence says often not by much.

For everyone, expect the comedown. As the drug wears off in the late afternoon or evening, irritability, fatigue, low mood, and difficulty thinking can hit hard. This is more pronounced with IR than XR and worse at higher doses. Sleep that night will probably be lighter and shorter than usual, with more wake-ups and reduced REM. The cumulative sleep debt is one of the major reasons people end up feeling worse on long-term Adderall than they expected.

With chronic use, the magic-pill quality fades. The dose that used to feel transformative starts to feel like baseline, and stopping it produces a noticeable functional drop. This isn't necessarily addiction in the clinical sense, but it is a kind of dependence that's worth being honest about.

Side effects & risks:

Cardiovascular: Elevated heart rate (typically 5-10 bpm) and blood pressure (typically 2-5 mmHg systolic) are near-universal. People with structural heart disease, uncontrolled hypertension, hyperthyroidism, or a family history of sudden cardiac death should not take Adderall without specialist clearance. Chest pain, palpitations, or fainting on the medication require immediate evaluation

Sleep: Insomnia, delayed sleep onset, reduced sleep quality. Effect can persist after the cognitive effect wears off. Don't dose after early afternoon

Appetite and weight: Significant appetite suppression and weight loss are expected. In adults this is usually manageable with scheduled meals; in growing children and adolescents it can affect growth trajectory

Anxiety, agitation, irritability: Common, dose-dependent. Can manifest as a tightly wound feeling, snappy mood, or full-blown anxiety. Often worse on the comedown

Dry mouth, headache, GI upset, sweating, dizziness: Common, usually tolerable, often improve over the first 1-2 weeks

Mood and psychiatric: Stimulants can unmask or worsen anxiety disorders, bipolar disorder, and psychosis. New paranoid thinking, grandiosity, or hallucinations require stopping the medication and speaking to a doctor. People with a family history of psychotic illness should be cautious

Sexual: Variable. Some people report increased libido, others report erectile dysfunction or anorgasmia. Often dose-dependent

Menstrual: The Adderall label lists painful menstrual cramps as a possible side effect. Some women report changes in cycle length or bleeding

Tolerance and dependence: Real and dose-dependent. Stimulant use disorder is a recognised condition. Risk is highest with high doses, IR formulations, recreational dosing patterns, and personal or family history of substance use disorder

Withdrawal: Stopping abruptly after sustained use produces fatigue, low mood, increased appetite, vivid dreams, and difficulty concentrating, lasting days to weeks. Worse after high-dose long-term use. Tapering is usually preferable

Drug interactions: MAOIs are an absolute contraindication, the combination can cause hypertensive crisis. SSRIs and SNRIs can interact (serotonin syndrome risk, especially at higher doses). Other stimulants, decongestants, and certain antidepressants compound cardiovascular load. Acidifying agents (vitamin C, fruit juices) reduce absorption; alkalinising agents (sodium bicarbonate) increase it

Pregnancy and breastfeeding: Generally avoided. Crosses the placenta, present in breast milk. Discuss with a specialist if you have severe ADHD and become pregnant

Schedule II controlled substance in the US and similarly restricted elsewhere. Diversion, sharing, and possession without a prescription carry serious legal consequences

🩸

Blood markers

Resting heart rate and blood pressure, baseline before starting and rechecked at 1 month, 3 months, then twice yearly. This is the single most important monitoring step. Sustained increases above your baseline warrant a dose review.

ECG, baseline if you have any cardiac history, family history of sudden cardiac death, structural heart concerns, or are over 40 starting stimulants for the first time. Not routinely needed in young healthy adults but the threshold to get one is low.

TSH, free T4, free T3, baseline. Hyperthyroidism mimics stimulant side effects and is a contraindication. Worth knowing your numbers before you can't tell which is which.

CBC and comprehensive metabolic panel (kidney and liver function, electrolytes), baseline and annually. Stimulants don't typically damage these but you want a reference, especially if appetite suppression is significant.

Weight, tracked. Both for safety (excessive loss) and for dosing (your dose is partly based on body mass, particularly for women).

Sleep, tracked subjectively or with a wearable. Sleep degradation is the most common silent cost of long-term Adderall and the easiest to ignore until it's wrecked your week.

Most people on a stable Adderall dose under specialist care don't need anything beyond annual vitals, BP, and a check-in. The people who actually need more workup are anyone over 40, anyone with cardiovascular risk factors, women noticing strong cycle-related variability, and anyone whose dose has been climbing.

Prescription-only Schedule II controlled substance in the US and a similarly restricted prescription medication in most other countries.